Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
Publ. Version/Full Text
DOI
PMC
 |
Open Access Gold (Paid Option) |
|
as soon as is submitted to ZB.
The use of continuous glucose monitoring in people living with obesity, intermediate hyperglycemia or type 2 diabetes.
Diabetes Res. Clin. Pract. 223:112111 (2025)
A global trend towards increased obesity, intermediate hyperglycemia (previously termed prediabetes) and type 2 diabetes, has prompted a range of international initiatives to proactively raise awareness and provide action-driven recommendations to prevent and manage these linked disease states. One approach, that has shown success in managing people already diagnosed with type 2 diabetes mellitus, is to use continuous glucose monitoring (CGM) devices to help them manage their chronic condition through understanding and treating their daily glucose fluctuations, in assocation with glucose-lowering medications, including insulin. However, much of the burden of type 2 diabetes mellitus is founded in the delayed detection both of type 2 diabetes mellitus itself, and the intermediate hyperglycaemia that precedes it. In this review, we provide evidence that using CGM technology in people at-risk of intermediate hyperglycaemia or type 2 diabetes mellitus can significantly improve the rate and timing of detection of dysglycaemia. Earlier detection allows intervention, including through continued use of CGM to guide changes to diet and lifestyle, that can delay or prevent harmful progression of early dysglycaemia. Although further research is needed to fully understand the cost-effectiveness of this intervention in people at-risk or with early dysglycemia, the proposition for use of CGM technology is clear.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Review
Keywords
Consensus Statements ; Continuous Glucose Monitoring ; Intermediate Hyperglycemia ; Obesity ; Prediabetes ; Type 2 Diabetes; Life-style Intervention; Follow-up; Glycemic Variability; Microvascular Complications; Severe Hypoglycemia; Insulin Injections; Consensus Report; Time; Association; Risk
ISSN (print) / ISBN
0168-8227
e-ISSN
1872-8227
Quellenangaben
Volume: 223,
Article Number: 112111
Publisher
Elsevier
Publishing Place
Elsevier House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000, Ireland
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Pancreatic Islet Research (IPI)
Grants
Medical Research Council Clinical Academic Partnership award
Slovenian Research and Inovation Agency
Slovenian Research and Inovation Agency